These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12625663)

  • 21. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
    Bharmal M; Thomas J
    Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding health state valuations: a qualitative analysis of respondents' comments.
    Devlin NJ; Hansen P; Selai C
    Qual Life Res; 2004 Sep; 13(7):1265-77. PubMed ID: 15473505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a MS specialist nurse programme.
    Forbes A; While A; Mathes L; Griffiths P
    Int J Nurs Stud; 2006 Nov; 43(8):985-1000. PubMed ID: 16412443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note.
    Kirigia JM
    Health Econ; 1998 Sep; 7(6):551-6. PubMed ID: 9809712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.
    Oppe M; Devlin NJ; van Hout B; Krabbe PF; de Charro F
    Value Health; 2014 Jun; 17(4):445-53. PubMed ID: 24969006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-state valuations for pertussis: methods for valuing short-term health states.
    Lee GM; Salomon JA; LeBaron CW; Lieu TA
    Health Qual Life Outcomes; 2005 Mar; 3():17. PubMed ID: 15780145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Description and valuation of health-related quality of life among the general public in Japan by the EuroQol.
    Hisashige A; Mikasa H; Katayama T
    J Med Invest; 1998 Aug; 45(1-4):123-9. PubMed ID: 9864973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
    Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
    Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social valuation of EQ-5D health states: the Chilean case.
    Zarate V; Kind P; Valenzuela P; Vignau A; Olivares-Tirado P; Munoz A
    Value Health; 2011 Dec; 14(8):1135-41. PubMed ID: 22152184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Learning effects in time trade-off based valuation of EQ-5D health states.
    Augestad LA; Rand-Hendriksen K; Kristiansen IS; Stavem K
    Value Health; 2012; 15(2):340-5. PubMed ID: 22433766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM; Martin ML; Ricci JF; Bracco A
    Value Health; 2006; 9(2):90-7. PubMed ID: 16626412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of differences between patient and general population EQ-5D-3L values on the mean tariff scores of different patient groups.
    Little MH; Reitmeir P; Peters A; Leidl R
    Value Health; 2014 Jun; 17(4):364-71. PubMed ID: 24968996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
    Chruzander C; Ytterberg C; Gottberg K; Einarsson U; Widén Holmqvist L; Johansson S
    J Neurol Sci; 2014 Apr; 339(1-2):57-63. PubMed ID: 24492009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK.
    Orme M; Kerrigan J; Tyas D; Russell N; Nixon R
    Value Health; 2007; 10(1):54-60. PubMed ID: 17261116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
    Yusof FA; Goh A; Azmi S
    Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between "loco-check" and EuroQol, a comprehensive instrument for assessing health-related quality of life: a study of the Japanese general population.
    Iizuka Y; Iizuka H; Mieda T; Tajika T; Yamamoto A; Takagishi K
    J Orthop Sci; 2014 Sep; 19(5):786-91. PubMed ID: 25023927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.